keyword
https://read.qxmd.com/read/38730072/efficacy-and-safety-of-adenosine-rapid-ventricular-pacing-and-hypothermia-in-cerebral-aneurysms-clipping-a-systematic-review-and-meta-analysis
#21
JOURNAL ARTICLE
Gabriela Borges Nager, Julia Pereira Muniz Pontes, Ofonime Chantal Udoma-Udofa, Fernando Cotrim Gomes, Anna Laura Lima Larcipretti, Jessica Sales de Oliveira, Caroline Serafim Dagostin, Mateus Neves Faria Fernandes, Matheus de Andrade Bannach
BACKGROUND AND OBJECTIVES: Cerebral aneurysms in complex anatomical locations and intraoperative rupture can be challenging. Many methods to reduce blood flow can facilitate its exclusion from the circulation. This study evaluated the safety and efficacy of using adenosine, rapid ventricular pacing, and hypothermia in cerebral aneurysm clipping. METHODS: Databases (PubMed, Embase, and Web of Science) were systematically searched for studies documenting the use of adenosine, rapid ventricular pacing, and hypothermia in cerebral aneurysm clipping and were included in this single-arm meta-analysis...
May 11, 2024: Neurosurgical Review
https://read.qxmd.com/read/38729913/percutaneous-intervention-of-a-giant-saphenous-venous-coronary-graft-aneurysm-in-an-octogenarian-with-stemi
#22
Abhishek Chaturvedi, Kalyan R Chitturi, Waiel Abusnina, Ron Waksman, Nelson L Bernardo
No abstract text is available yet for this article.
April 8, 2024: Cardiovascular Revascularization Medicine: Including Molecular Interventions
https://read.qxmd.com/read/38729903/post-liver-transplant-short-term-and-survival-outcomes-in-patients-living-with-obesity
#23
JOURNAL ARTICLE
Ramanpreet Bajwa, Lovepreet Singh, Sofia Molina Garcia, Kristelle Imperio-Lagabon, Omar T Sims, Jamak Modaresi Esfeh
The objectives of our study were to examine and compare patient and graft survival over a 5-year period across BMI groups, and examine immediate and short-term complications post-LT. This was a retrospective study that examined all liver transplants that occurred at our institution between January 2015-October 2022. Patients were divided into 4 BMI groups (n = 888): normal-overweight (BMI 18.5- 29.9 kg/m2 ), class I obesity (BMI 30-34.9 kg/m2 ), class II obesity (BMI 35-39.9 kg/m2 ), and class III obesity (BMI ≥40 kg/m2 ) patients...
May 9, 2024: Digestive and Liver Disease
https://read.qxmd.com/read/38729604/contemporary-outcomes-of-acute-coronary-syndromes-in-indigenous-compared-with-non-indigenous-patients-a-northern-saskatchewan-perspective
#24
JOURNAL ARTICLE
Jay S Shavadia, Udoka Okpalauwaekwe, Minyoung Kim, Jason Orvold, Colin Pearce, Alexandra King, Kehinde Ametepee, Haissam Haddad
BACKGROUND: In patients presenting with an acute coronary syndrome (ACS), the impact of efforts leveraged at bridging historical care gaps between Indigenous and non-Indigenous patients remains limited. METHODS: For consecutive ACS presentations (STEMI and NSTEMI/UA, respectively) at the Royal University Hospital, Saskatoon, we compared between self-identified Indigenous and non-Indigenous patients their demographics, treatments and all-cause mortality (in-hospital and 3-years)...
May 8, 2024: Canadian Journal of Cardiology
https://read.qxmd.com/read/38729576/perioperative-management-and-outcomes-in-patients-receiving-low-dose-rivaroxaban-and-or-aspirin-a-sub-analysis-of-the-compass-trial
#25
JOURNAL ARTICLE
James D Douketis, Qilong Yi, Deepak L Bhatt, Eva Muehlhofer, Michael K Wang, Stuart Connolly, Salim Yusuf, Aldo P Maggioni, John W Eikelboom
BACKGROUND: No study has investigated the perioperative management and clinical outcomes in patients who are receiving rivaroxaban 2.5 mg bid and ASA 81-100 mg daily. METHODS: Sub-analysis of the COMPASS trial to assess perioperative management and clinical outcomes in patients with stable coronary or peripheral artery disease who were randomized to receive rivaroxaban 2.5 mg bid plus ASA 100 mg daily, rivaroxaban 5 mg bid, or ASA 100 mg daily. Patients studied required a surgery/procedure during the trial...
May 8, 2024: Journal of Thrombosis and Haemostasis: JTH
https://read.qxmd.com/read/38729464/progresses-and-perspectives-on-natural-polysaccharide-based-hydrogels-for-repair-of-infarcted-myocardium
#26
JOURNAL ARTICLE
Pallabita Rakshit, Tapan Kumar Giri, Kaushik Mukherjee
Myocardial infarction (MI) is serious health threat and impairs the quality of life. It is a major causative factor of morbidity and mortality. MI leads to the necrosis of cardio-myocytes, cardiac remodelling and dysfunction, eventually leading to heart failure. The limitations of conventional therapeutic and surgical interventions and lack of heart donors have necessitated the evolution of alternate treatment approaches for MI. Polysaccharide hydrogel based repair of infarcted myocardium have surfaced as viable option for MI treatment...
May 8, 2024: International Journal of Biological Macromolecules
https://read.qxmd.com/read/38729389/long-term-outcome-of-risankizumab-in-crohn-s-disease-a-real-world-getaid-study
#27
JOURNAL ARTICLE
Mathurin Fumery, Benedicte Caron, Xavier Hébuterne, Romain Altwegg, Xavier Roblin, Carmen Stefanescu, Antoine Meyer, Maria Nachury, David Laharie, Catherine Le Berre, Lucas Guillo, Amélie Biron, Ludovic Caillo, Anthony Buisson, Stephane Nancey, Mathieu Uzzan, Lucine Vuitton, Cyrielle Gilletta, Sophie Geyl, Antoine Blain, Julien Kirchgesner, Philippe Ah-Soune, Nicolas Duveau, Mathias Vidon, Vered Abitbol, Thierry Paupard, My-Linh Tran-Minh, Antoine Defrance, Laurent Peyrin-Biroulet
INTRODUCTION: The aim of this study was to assess the long-term effectiveness and safety of risankizumab maintenance treatment in a large real-world cohort of patients with CD. PATIENTS AND METHODS: From May 2021 to August 2023, all consecutive CD patients treated with risankizumab in 25 GETAID centers have been retrospectively included. The primary endpoint was steroid-free clinical remission (Harvey Bradshaw Index (HBI) <5) at 52 weeks. RESULTS: Of the 174 patients included, 99%, 93%, and 96% had been previously exposed to anti-TNF, vedolizumab, and ustekinumab, respectively...
May 8, 2024: Clinical Gastroenterology and Hepatology
https://read.qxmd.com/read/38729348/intra-hospital-variation-of-gut-microbiota-product-trimethylamine-n-oxide-tmao-predicts-future-major-adverse-cardiovascular-events-after-myocardial-infarction
#28
JOURNAL ARTICLE
Aneta Aleksova, Alessandra Lucia Fluca, Mariano Stornaiuolo, Giulia Barbati, Alessandro Pierri, Donna R Zwas, Daniela Santon, Stefano D'Errico, Maria Marketou, Gianfranco Sinagra, Yosefa Avraham, Ettore Novellino, Milijana Janjusevic
BACKGROUND AND AIMS: Trimethylamine N-oxide (TMAO) has been associated with atherosclerosis and poor outcome. We evaluated the prognostic impact of intra-hospital TMAO variation on patient outcome. METHODS AND RESULTS: Blood samples from 149 patients with acute myocardial infarction (AMI) were taken on admission and discharge. Plasma TMAO was determined by HPLC-MS. The endpoint was a composite three-point MACE (major adverse cardiovascular events) including all-cause mortality, re-infarction or the heart failure (HF) development...
May 8, 2024: Hellenic Journal of Cardiology: HJC
https://read.qxmd.com/read/38729343/stasis-imaging-predicts-the-risk-of-cardioembolic-events-related-to-acute-myocardial-infarction
#29
JOURNAL ARTICLE
Elena Rodríguez-González, Pablo Martínez-Legazpi, Teresa Mombiela, Ana González-Mansilla, Antonia Delgado-Montero, Juan A Guzmán-De-Villoria, Fernando Díaz-Otero, Raquel Prieto-Arévalo, Miriam Juárez, María Del Carmen García Del Rey, Pilar Fernández-García, Óscar Flores, Andrea Postigo, Raquel Yotti, Manuel García-Villalba, Francisco Fernández-Avilés, Juan C Del Álamo, Javier Bermejo
INTRODUCTION AND OBJECTIVES: In the setting of ST-segment elevation myocardial infarction (STEMI), imaging-based biomarkers could be useful for guiding oral anticoagulation to prevent cardioembolism. Our objective was to test the efficacy of intraventricular blood stasis imaging in predicting a composite primary endpoint of cardioembolic risk during the first 6 months after STEMI. METHODS: We designed a prospective clinical study, Imaging Silent Brain Infarct in Acute Myocardial Infarction (ISBITAMI, NCT02917213), including patients with a first STEMI, an ejection fraction ≤ 45% and without atrial fibrillation to assess the performance of stasis metrics to predict cardioembolism...
May 8, 2024: Revista Española de Cardiología
https://read.qxmd.com/read/38729335/transcatheter-aortic-valve-replacement-in-low-surgical-risk-patients-an-updated-metanalysis-of-extended-follow-up-randomized-controlled-trials
#30
JOURNAL ARTICLE
Gianluca Di Pietro, Riccardo Improta, Ovidio De Filippo, Francesco Bruno, Lucia Ilaria Birtolo, Marco Tocci, Tommaso Fabris, Wael Saade, Riccardo Colantonio, Paola Celli, Gennaro Sardella, Giovanni Esposito, Giuseppe Tarantini, Mancone Massimo, Fabrizio D'Ascenzo
The long-term safety and effectiveness of transcatheter aortic valve replacement (TAVR) compared to surgical aortic valve replacement (SAVR) in low surgical risk has not been evaluated in a pooled analysis. An electronic database search was conducted for randomized controlled trials (RCTs) with a maximal 5 years clinical and echocardiographic follow-up including low surgical risk patients underwent TAVR or SAVR. We calculated Odds Ratio (OD) and 95% confidence intervals (CIs) using a random-effects model. Subgroups analysis was performed for PPI and PVLs...
May 8, 2024: American Journal of Cardiology
https://read.qxmd.com/read/38729022/research-and-application-of-hydrogel-encapsulated-mesenchymal-stem-cells-in-the-treatment-of-myocardial-infarction
#31
REVIEW
Haien Guan, Yuehua Chen, Xuanyu Liu, Li Huang
Myocardial infarction (MI) stands out as a highly lethal disease that poses a significant threat to global health. Worldwide, heart failure resulting from MI remains a leading cause of human mortality. Mesenchymal stem cell (MSC) therapy has emerged as a promising therapeutic approach, leveraging its intrinsic healing properties. Nevertheless, pervasive issues, including a low cell retention rate, suboptimal survival rate, and incomplete differentiation of MSCs, present formidable challenges for further research...
May 6, 2024: Colloids and Surfaces. B, Biointerfaces
https://read.qxmd.com/read/38728881/m6a-epitranscriptomic-modification-of-inflammation-in-cardiovascular-disease
#32
REVIEW
Yun-Sen Zhang, Zhi-Yan Liu, Zhen-Yu Liu, Li-Chan Lin, Qi Chen, Jian-Yuan Zhao, Hui Tao
Cardiovascular disease is currently the number one cause of death endangering human health. There is currently a large body of research showing that the development of cardiovascular disease and its complications is often accompanied by inflammatory processes. In recent years, epitranscriptional modifications have been shown to be involved in regulating the pathophysiological development of inflammation in cardiovascular diseases, with 6-methyladenine being one of the most common RNA transcriptional modifications...
May 9, 2024: International Immunopharmacology
https://read.qxmd.com/read/38728685/development-and-validation-of-an-explainable-deep-learning-model-to-predict-in-hospital-mortality-for-patients-with-acute-myocardial-infarction-algorithm-development-and-validation-study
#33
MULTICENTER STUDY
Puguang Xie, Hao Wang, Jun Xiao, Fan Xu, Jingyang Liu, Zihang Chen, Weijie Zhao, Siyu Hou, Dongdong Wu, Yu Ma, Jingjing Xiao
BACKGROUND: Acute myocardial infarction (AMI) is one of the most severe cardiovascular diseases and is associated with a high risk of in-hospital mortality. However, the current deep learning models for in-hospital mortality prediction lack interpretability. OBJECTIVE: This study aims to establish an explainable deep learning model to provide individualized in-hospital mortality prediction and risk factor assessment for patients with AMI. METHODS: In this retrospective multicenter study, we used data for consecutive patients hospitalized with AMI from the Chongqing University Central Hospital between July 2016 and December 2022 and the Electronic Intensive Care Unit Collaborative Research Database...
May 10, 2024: Journal of Medical Internet Research
https://read.qxmd.com/read/38728681/is-electronic-information-exchange-associated-with-lower-30-day-readmission-charges-among-medicare-beneficiaries
#34
JOURNAL ARTICLE
Sara D Turbow, Puneet K Chehal, Steven D Culler, Camille P Vaughan, Christina Offutt, Kimberly J Rask, Molly M Perkins, Carolyn K Clevenger, Mohammed K Ali
OBJECTIVE: Fragmented readmissions, when admission and readmission occur at different hospitals, are associated with increased charges compared with nonfragmented readmissions. We assessed if hospital participation in health information exchange (HIE) was associated with differences in total charges in fragmented readmissions. DATA SOURCE: Medicare Fee-for-Service Data, 2018. STUDY DESIGN: We used generalized linear models with hospital referral region and readmission month fixed effects to assess relationships between information sharing (same HIE, different HIEs, and no HIE available) and total charges of 30-day readmissions among fragmented readmissions; analyses were adjusted for patient-level clinical/demographic characteristics and hospital-level characteristics...
June 1, 2024: Medical Care
https://read.qxmd.com/read/38727645/the-rise-of-t2
#35
EDITORIAL
Eike Nagel, Laura Pappas
No abstract text is available yet for this article.
April 27, 2024: JACC. Cardiovascular Imaging
https://read.qxmd.com/read/38727642/dual-layered-micromesh-stent-technology-for-embolic-prevention-in-carotid-revascularization-technical-experience-and-clinical-outcomes-from-a-high-volume-interventional-radiology-center
#36
JOURNAL ARTICLE
Matteo Stefanini, Laura M Cacioppa, Luigi Bellini, Luca Ginanni Corradini, Adolfo D'Onofrio, Giovanni Simonetti
BACKGROUND: Carotid artery stenting (CAS) has become a cornerstone of carotid revascularization for stroke prevention. Despite the advantages of CAS, large-scale randomized trials involving prior (single-layer) generation of carotid stents demonstrated its higher risk of periprocedural cerebrovascular events compared to carotid endarterectomy (CEA). Dual-layer mesh-covered stents (DLSs) showed promising results in terms of 30-day embolic events. This study aims to evaluate 30-day clinical efficacy of DLS against a closed-cell single-layer stent, based on large-volume data...
May 10, 2024: Journal of Cardiovascular Surgery
https://read.qxmd.com/read/38727300/targeting-interactions-between-fibroblasts-and-macrophages-to-treat-cardiac-fibrosis
#37
REVIEW
Bo Yang, Yan Qiao, Dong Yan, Qinghang Meng
Excessive extracellular matrix (ECM) deposition is a defining feature of cardiac fibrosis. Most notably, it is characterized by a significant change in the concentration and volume fraction of collagen I, a disproportionate deposition of collagen subtypes, and a disturbed ECM network arrangement, which directly affect the systolic and diastolic functions of the heart. Immune cells that reside within or infiltrate the myocardium, including macrophages, play important roles in fibroblast activation and consequent ECM remodeling...
April 30, 2024: Cells
https://read.qxmd.com/read/38727189/a-lucky-or-unlucky-survivor-a-blunt-trauma-induced-myocardial-infarction-case
#38
JOURNAL ARTICLE
Yong Luo, Li Zhang
No abstract text is available yet for this article.
May 13, 2024: Coronary Artery Disease
https://read.qxmd.com/read/38726918/ten-year-outcome-of-recanalization-or-medical-therapy-for-concomitant-chronic-total-occlusion-after-myocardial-infarction
#39
JOURNAL ARTICLE
Anna van Veelen, Casper F Coerkamp, Yvemarie B O Somsen, Truls Råmunddal, Dan Ioanes, Peep Laanmets, René J van der Schaaf, Erlend Eriksen, Matthijs Bax, Maarten Jan Suttorp, Bradley H Strauss, Emanuele Barbato, Koen M Marques, Martijn Meuwissen, Olivier Bertrand, Martin van der Ent, Paul Knaapen, Jan G P Tijssen, Bimmer E P M Claessen, Loes P C Hoebers, Joëlle Elias, José P S Henriques
BACKGROUND: The EXPLORE (Evaluating Xience and Left Ventricular Function in PCI on Occlusions After STEMI) trial was the first and only randomized trial investigating chronic total occlusion (CTO) percutaneous coronary intervention (PCI) early after primary PCI for ST-segment-elevation myocardial infarction, compared with medical therapy for the CTO. We performed a 10-year follow-up of EXPLORE to investigate long-term safety and clinical impact of CTO PCI after ST-segment-elevation myocardial infarction, compared with no-CTO PCI...
May 10, 2024: Journal of the American Heart Association
https://read.qxmd.com/read/38726915/five-year-cumulative-cardiovascular-health-and-clinical-events-in-patients-with-chronic-kidney-disease-the-cric-study
#40
JOURNAL ARTICLE
Qiuyu Cao, Yufang Bi, Flor Alvarado, Amanda H Anderson, Katherine T Mills, Byron C Jaeger, Jing Chen, Jiang He, Joshua D Bundy
BACKGROUND: Higher cardiovascular health (CVH) score is associated with lower risks of cardiovascular disease (CVD) and mortality in the general population. However, it is unclear whether cumulative CVH is associated with CVD, end-stage kidney disease (ESKD), and death in patients with chronic kidney disease. METHODS AND RESULTS: Among individuals from the prospective CRIC (Chronic Renal Insufficiency Cohort) Study, we used the percentage of the maximum possible CVH score attained from baseline to the year 5 visit to calculate cumulative CVH score...
May 10, 2024: Journal of the American Heart Association
keyword
keyword
26671
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.